Last updated on November 2017

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

Other Details:

For more information:
Contact: Celldex Therapeutics

Contact Investigators or Research Sites near you

Start Over

Branimir Sikic, MD

The Stanford Center for Clinical and Translational Education and Research Recruiting
Palo Alto, CA USA